Switching from biosimilar adalimumab to originator adalimumab and vice versa as an alternative to target switch in patients with hidradenitis suppurativa: a single center experience

被引：0
|
作者：
Roldan, Fernando Alfageme [1 ]
Cembrero, Hirune [1 ]
Salguero, Irene [1 ]
Martinez, Constanza [1 ]
Roustan, Gaston [1 ]
机构：
[1] Hosp Univ Puerta de Hierro Majadahonda, Dermatol, Madrid, Spain
来源：
EXPERIMENTAL DERMATOLOGY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P167
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [41] Use of Adalimumab Biosimilar (exemptia) In Complicated IBD Patients, Single Centre Experience
    Dudhe, Hitesh
    Reddy, Vamsidhar
    Adi, Rakesh Kumar
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 644 - 644
  • [42] Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be)
    Daoud, Mathieu
    Benhadou, Farida
    Suppa, Mariano
    Sarkis, Anne-Sophie
    Heudens, Stephanie
    Desmarest, Lila
    Njimi, Hassane
    Daxhelet, Mathilde
    Nobile, Laura
    Karama, Jalila
    White, Jonathan M.
    Jemec, Gregor B. E.
    del Marmol, Veronique
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [43] DIFFERENT FAILURE RATES AFTER NON-MEDICAL SWITCHING 744 PATIENTS FROM ADALIMUMAB ORIGINATOR TO 2 ADALIMUMAB BIOSIMILARS
    Rosembert, Denise
    Malaviya, Anshuman
    How, Jane
    Toh, Fiona
    Tomlinson, Jacqueline
    Nightingale, Allison
    Garcia-Sueiro, Cristina
    Herbert, Pippa
    Magsino, Julien
    Roe, Maria
    Jadon, Deepak
    Norris, Paul
    Raine, Tim
    GUT, 2021, 70 : A115 - A115
  • [44] Long-term outcomes following a switch from originator adalimumab to the biosimilar SB5 (Imraldi) in IBD
    Derikx, L.
    Dolby, H.
    Plevris, N.
    Lucaciu, L.
    Rees, C.
    Lyons, M.
    Siakavellas, S.
    Constantine-Cooke, N.
    Noble, C.
    O'Hare, C.
    Merchant, L.
    Arnott, I.
    Jones, G. R.
    Lees, C.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S353 - S354
  • [45] Comparison of discontinuation/switching between adalimumab biosimilar and originator in Inflammatory Bowel Disease patients: Preliminary data from CAN-AIM
    Lukusa, L.
    Birck, M. G.
    Moura, C. S.
    Neville, A.
    Zezos, P.
    Narula, N.
    Targownik, L. E.
    Ma, C.
    Purdy, E.
    Afif, W.
    Singh, H.
    Oketola, B.
    Bernatsky, S.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I2069 - I2070
  • [46] Effectiveness of non-medical switch from adalimumab bio-originator to SB5 biosimilar and from ABP501 adalimumab biosimilar to SB5 biosimilar in patients with chronic inflammatory arthropathies: a monocentric observational study
    Scrivo, R.
    Castellani, C.
    Mancuso, S.
    Sciarra, G.
    Giardina, F.
    Bevignani, G.
    Ceccarelli, F.
    Spinelli, F. R.
    Alessandri, C.
    Di Franco, M.
    Riccieri, V.
    Priori, R.
    Conti, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (03) : 613 - 619
  • [47] Smoking Status shows no Impact on the Treatment Response with Adalimumab in Patients with Hidradenitis suppurativa - Results from the German Hidradenitis Suppurativa Registry HSBest
    Kirsten, Natalia
    Ohm, Frenz
    Gehrdau, Kathrin
    Stephan, Brigitte
    Ben-Anaya, Nesrine
    Pinter, Andreas
    Bechara, Falk
    Presser, Dagmar
    Zouboulis, Christos
    Podda, Maurizio
    Augustin, Matthias
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 114 - 115
  • [48] Maintenance of clinical remission with SB5 biosimilar after switch from adalimumab originator: Real-life experience of a tertiary referral centre
    Dragoni, G.
    Pieraccini, A.
    Bagnoli, S.
    Caini, S.
    Macri, G.
    Rogai, F.
    Milani, S.
    Galli, A.
    Milla, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S515 - S515
  • [49] Golimumab, as an alternative treatment in patients with coexisting hidradenitis suppurativa and arthritis after adalimumab failure: Report of two cases
    Ramos, Francisco Javier Melgosa
    Ruiz, Ramon Garcia
    Puchades, Almudena Mateu
    DERMATOLOGIC THERAPY, 2022, 35 (03)
  • [50] Persistence After Switching From Adalimumab Biosimilar MSB11022 to Adalimumab Biosimilar GP2017 in Patients With Chronic Inflammatory Rheumatic Diseases
    Borras-Blasco, Joaquin
    Valcuende-Rosique, Alejandro
    Cornejo, Silvia
    Aparicio-Rubio, Celia
    Aguilar-Zamora, Marta
    Garijo-Bufort, Marta
    Arevalo-Ruales, Karla Romelia
    JOURNAL OF PHARMACY TECHNOLOGY, 2025, 41 (02) : 90 - 94
12345